Literature DB >> 18275928

Environmental factors and multiple sclerosis.

George C Ebers1.   

Abstract

Studies in Canada have provided strong evidence that environmental factors act at a population level to influence the unusual geographical distribution of multiple sclerosis (MS). However, the available data accommodate more than one type of environmental effect. Migration studies show that changes to early environment can greatly affect risk, and there are recent indications that risk can be altered in situ. The rising incidence rates of MS in Canada implied by longitudinal increases in sex ratio place this effect in temporal context and narrow the candidates for mediating the effect of environment. Similarly, geographical patterns in Australia imply that modifiable environmental factors hold the key to preventing some 80% of cases. Genetic epidemiology provides overwhelming evidence that genetic background has an important complementary role. If genetic factors are held constant, the environment sets the disease threshold. Although these could be independent additive risk factors, it seems more likely that susceptibility is mediated by direct interactions between the environment and genes.

Entities:  

Mesh:

Year:  2008        PMID: 18275928     DOI: 10.1016/S1474-4422(08)70042-5

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  165 in total

1.  Migration and multiple sclerosis in United Kingdom and Ireland immigrants to Australia: a reassessment. II. Characteristics of early (pre-1947) compared to later migrants.

Authors:  J G McLeod; S R Hammond; J F Kurtzke
Journal:  J Neurol       Date:  2011-09-23       Impact factor: 4.849

2.  UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.

Authors:  Bryan R Becklund; Kyle S Severson; Souriya V Vang; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

3.  MHC transmission: insights into gender bias in MS susceptibility.

Authors:  M J Chao; S V Ramagopalan; B M Herrera; S M Orton; L Handunnetthi; M R Lincoln; D A Dyment; A D Sadovnick; G C Ebers
Journal:  Neurology       Date:  2011-01-05       Impact factor: 9.910

4.  Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in France.

Authors:  Amélie Darlix; Sonia Zouaoui; Jean-Marc Virion; Valérie Rigau; Hélène Mathieu-Daudé; Marie Blonski; German Reyes-Botero; Faiza Bessaoud; Brigitte Trétarre; Fabienne Bauchet; Laurent Capelle; Michel Fabbro; Christine Kerr; Dominique Figarella-Branger; Hugues Duffau; Luc Taillandier; Luc Bauchet
Journal:  J Neurooncol       Date:  2014-08-24       Impact factor: 4.130

5.  Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells.

Authors:  Dimitry N Krementsov; Rajkumar Noubade; Julie A Dragon; Kinya Otsu; Mercedes Rincon; Cory Teuscher
Journal:  Ann Neurol       Date:  2014-01       Impact factor: 10.422

6.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

7.  Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.

Authors:  Anthony L Traboulsee; Cecily Q Bernales; Jay P Ross; Joshua D Lee; A Dessa Sadovnick; Carles Vilariño-Güell
Journal:  Neurogenetics       Date:  2014-04-26       Impact factor: 2.660

8.  Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific.

Authors:  Dimitry N Krementsov; Laure K Case; William F Hickey; Cory Teuscher
Journal:  FASEB J       Date:  2015-04-27       Impact factor: 5.191

Review 9.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

10.  MYO9B polymorphisms in multiple sclerosis.

Authors:  Anu Kemppinen; Minna Suvela; Pentti J Tienari; Irina Elovaara; Keijo Koivisto; Tuula Pirttilä; Mauri Reunanen; Ilkka Rautakorpi; Jan Hillert; Frida Lundmark; Annette Oturai; Lars Ryder; Hanne F Harbo; Elisabeth G Celius; Aarno Palotie; Mark Daly; Leena Peltonen; Janna Saarela
Journal:  Eur J Hum Genet       Date:  2009-01-14       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.